Detalles de la búsqueda
1.
An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.
Gynecol Oncol
; 159(3): 721-731, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32988624
2.
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients.
Clin Lung Cancer
; 23(3): e243-e246, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34393061
3.
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study.
Cancers (Basel)
; 14(23)2022 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36497361
4.
First-line osimertinib in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met.
Eur J Cancer
; 159: 174-181, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34763195
5.
Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 5: 93-102, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994593
6.
MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice.
JNCI Cancer Spectr
; 5(4)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34377934
7.
Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study.
Clin Breast Cancer
; 19(2): 105-112, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30679100
8.
A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial.
Breast
; 23(5): 656-62, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25047747
Resultados
1 -
8
de 8
1
Próxima >
>>